Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans

M. Hollingdal, C. B. Juhl, R. Dall, J. Sturis, Johannes D Veldhuis, O. Schmitz, N. Pørksen

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is characterized by abnormal insulin secretion, which involves a disrupted basal and glucose-entrained insulin pulsatility, and by insulin resistance. The aim of this study was to examine the influence of glucocorticoid-mediated insulin resistance on the regularity of high frequency insulin pulsatility. Methods. Eight healthy men (means ± SD; age 24.4 ± 0.5 years, BMI 23.2 ± 0.7 kg/m2) were examined after prednisolone treatment (30 mg/day) or placebo for 6 days in a double-blind, placebo controlled, cross-over study with a 6-week washout period. Blood was collected every minute for 60 min during baseline and glucose-entrainment. Time-series were assessed by spectral and autocorrelation analyses and a first-phase insulin secretion test was carried out. Results. Prednisolone treatment led to insulin resistance as expected (HOMA-S; prednisolone vs placebo; 1.85 ± 0.26 vs 1.02 ± 0.10; p < 0.01) with exaggerated first-phase insulin secretion (3016 ± 468 pmol/l s 1688 ± 207 pmol/l; p < 0.01), suggesting a stable disposition index. During baseline, normalized spectral power of serum insulin concentration time-series was reduced during prednisolone exposure compared with placebo (8.40 ± 0.95 vs 11.79 ± 1.66;p < 0.05) indicating a disturbed high-frequency oscillatory insulin release. A similar trend was observed using autocorrelation analysis (0.23 ± 0.04 vs 0.32 ± 0.07; p = 0.12). During glucose entrainment no difference in normalized spectral power or in the autocorrelation coefficient between prednisolone and placebo (p > 0.1) was observed. Conclusion/interpretation. Six days of prednisolone treatment resulted in a pertubed high-frequency insulin release in the fasting state whereas the ability of glucose to entrain insulin secretion was preserved. This indicates a mechanism of pertubed glucose-insulin feedback mechanism which causes irregular oscillatory insulin release.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalDiabetologia
Volume45
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Glucocorticoids
Insulin Resistance
Insulin
Glucose
Prednisolone
Placebos
Aptitude
Cross-Over Studies
Type 2 Diabetes Mellitus
Fasting
Therapeutics

Keywords

  • Autocorrelation
  • Deconvolution
  • Glucose entrainment
  • High frequency insulin pulsatility
  • Insulin resistance
  • Prednisolone
  • Spectral analysis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Hollingdal, M., Juhl, C. B., Dall, R., Sturis, J., Veldhuis, J. D., Schmitz, O., & Pørksen, N. (2002). Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. Diabetologia, 45(1), 49-55. https://doi.org/10.1007/s125-002-8244-y

Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. / Hollingdal, M.; Juhl, C. B.; Dall, R.; Sturis, J.; Veldhuis, Johannes D; Schmitz, O.; Pørksen, N.

In: Diabetologia, Vol. 45, No. 1, 2002, p. 49-55.

Research output: Contribution to journalArticle

Hollingdal, M, Juhl, CB, Dall, R, Sturis, J, Veldhuis, JD, Schmitz, O & Pørksen, N 2002, 'Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans', Diabetologia, vol. 45, no. 1, pp. 49-55. https://doi.org/10.1007/s125-002-8244-y
Hollingdal, M. ; Juhl, C. B. ; Dall, R. ; Sturis, J. ; Veldhuis, Johannes D ; Schmitz, O. ; Pørksen, N. / Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. In: Diabetologia. 2002 ; Vol. 45, No. 1. pp. 49-55.
@article{7d314087a28f4913a0807567fb036456,
title = "Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans",
abstract = "Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is characterized by abnormal insulin secretion, which involves a disrupted basal and glucose-entrained insulin pulsatility, and by insulin resistance. The aim of this study was to examine the influence of glucocorticoid-mediated insulin resistance on the regularity of high frequency insulin pulsatility. Methods. Eight healthy men (means ± SD; age 24.4 ± 0.5 years, BMI 23.2 ± 0.7 kg/m2) were examined after prednisolone treatment (30 mg/day) or placebo for 6 days in a double-blind, placebo controlled, cross-over study with a 6-week washout period. Blood was collected every minute for 60 min during baseline and glucose-entrainment. Time-series were assessed by spectral and autocorrelation analyses and a first-phase insulin secretion test was carried out. Results. Prednisolone treatment led to insulin resistance as expected (HOMA-S; prednisolone vs placebo; 1.85 ± 0.26 vs 1.02 ± 0.10; p < 0.01) with exaggerated first-phase insulin secretion (3016 ± 468 pmol/l s 1688 ± 207 pmol/l; p < 0.01), suggesting a stable disposition index. During baseline, normalized spectral power of serum insulin concentration time-series was reduced during prednisolone exposure compared with placebo (8.40 ± 0.95 vs 11.79 ± 1.66;p < 0.05) indicating a disturbed high-frequency oscillatory insulin release. A similar trend was observed using autocorrelation analysis (0.23 ± 0.04 vs 0.32 ± 0.07; p = 0.12). During glucose entrainment no difference in normalized spectral power or in the autocorrelation coefficient between prednisolone and placebo (p > 0.1) was observed. Conclusion/interpretation. Six days of prednisolone treatment resulted in a pertubed high-frequency insulin release in the fasting state whereas the ability of glucose to entrain insulin secretion was preserved. This indicates a mechanism of pertubed glucose-insulin feedback mechanism which causes irregular oscillatory insulin release.",
keywords = "Autocorrelation, Deconvolution, Glucose entrainment, High frequency insulin pulsatility, Insulin resistance, Prednisolone, Spectral analysis",
author = "M. Hollingdal and Juhl, {C. B.} and R. Dall and J. Sturis and Veldhuis, {Johannes D} and O. Schmitz and N. P{\o}rksen",
year = "2002",
doi = "10.1007/s125-002-8244-y",
language = "English (US)",
volume = "45",
pages = "49--55",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans

AU - Hollingdal, M.

AU - Juhl, C. B.

AU - Dall, R.

AU - Sturis, J.

AU - Veldhuis, Johannes D

AU - Schmitz, O.

AU - Pørksen, N.

PY - 2002

Y1 - 2002

N2 - Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is characterized by abnormal insulin secretion, which involves a disrupted basal and glucose-entrained insulin pulsatility, and by insulin resistance. The aim of this study was to examine the influence of glucocorticoid-mediated insulin resistance on the regularity of high frequency insulin pulsatility. Methods. Eight healthy men (means ± SD; age 24.4 ± 0.5 years, BMI 23.2 ± 0.7 kg/m2) were examined after prednisolone treatment (30 mg/day) or placebo for 6 days in a double-blind, placebo controlled, cross-over study with a 6-week washout period. Blood was collected every minute for 60 min during baseline and glucose-entrainment. Time-series were assessed by spectral and autocorrelation analyses and a first-phase insulin secretion test was carried out. Results. Prednisolone treatment led to insulin resistance as expected (HOMA-S; prednisolone vs placebo; 1.85 ± 0.26 vs 1.02 ± 0.10; p < 0.01) with exaggerated first-phase insulin secretion (3016 ± 468 pmol/l s 1688 ± 207 pmol/l; p < 0.01), suggesting a stable disposition index. During baseline, normalized spectral power of serum insulin concentration time-series was reduced during prednisolone exposure compared with placebo (8.40 ± 0.95 vs 11.79 ± 1.66;p < 0.05) indicating a disturbed high-frequency oscillatory insulin release. A similar trend was observed using autocorrelation analysis (0.23 ± 0.04 vs 0.32 ± 0.07; p = 0.12). During glucose entrainment no difference in normalized spectral power or in the autocorrelation coefficient between prednisolone and placebo (p > 0.1) was observed. Conclusion/interpretation. Six days of prednisolone treatment resulted in a pertubed high-frequency insulin release in the fasting state whereas the ability of glucose to entrain insulin secretion was preserved. This indicates a mechanism of pertubed glucose-insulin feedback mechanism which causes irregular oscillatory insulin release.

AB - Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is characterized by abnormal insulin secretion, which involves a disrupted basal and glucose-entrained insulin pulsatility, and by insulin resistance. The aim of this study was to examine the influence of glucocorticoid-mediated insulin resistance on the regularity of high frequency insulin pulsatility. Methods. Eight healthy men (means ± SD; age 24.4 ± 0.5 years, BMI 23.2 ± 0.7 kg/m2) were examined after prednisolone treatment (30 mg/day) or placebo for 6 days in a double-blind, placebo controlled, cross-over study with a 6-week washout period. Blood was collected every minute for 60 min during baseline and glucose-entrainment. Time-series were assessed by spectral and autocorrelation analyses and a first-phase insulin secretion test was carried out. Results. Prednisolone treatment led to insulin resistance as expected (HOMA-S; prednisolone vs placebo; 1.85 ± 0.26 vs 1.02 ± 0.10; p < 0.01) with exaggerated first-phase insulin secretion (3016 ± 468 pmol/l s 1688 ± 207 pmol/l; p < 0.01), suggesting a stable disposition index. During baseline, normalized spectral power of serum insulin concentration time-series was reduced during prednisolone exposure compared with placebo (8.40 ± 0.95 vs 11.79 ± 1.66;p < 0.05) indicating a disturbed high-frequency oscillatory insulin release. A similar trend was observed using autocorrelation analysis (0.23 ± 0.04 vs 0.32 ± 0.07; p = 0.12). During glucose entrainment no difference in normalized spectral power or in the autocorrelation coefficient between prednisolone and placebo (p > 0.1) was observed. Conclusion/interpretation. Six days of prednisolone treatment resulted in a pertubed high-frequency insulin release in the fasting state whereas the ability of glucose to entrain insulin secretion was preserved. This indicates a mechanism of pertubed glucose-insulin feedback mechanism which causes irregular oscillatory insulin release.

KW - Autocorrelation

KW - Deconvolution

KW - Glucose entrainment

KW - High frequency insulin pulsatility

KW - Insulin resistance

KW - Prednisolone

KW - Spectral analysis

UR - http://www.scopus.com/inward/record.url?scp=0036160497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036160497&partnerID=8YFLogxK

U2 - 10.1007/s125-002-8244-y

DO - 10.1007/s125-002-8244-y

M3 - Article

C2 - 11845223

AN - SCOPUS:0036160497

VL - 45

SP - 49

EP - 55

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 1

ER -